echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > China Resources Double Crane: the first domestic irbesartan dispersible tablet to pass the consistency evaluation

    China Resources Double Crane: the first domestic irbesartan dispersible tablet to pass the consistency evaluation

    • Last Update: 2021-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 4, China Resources Double Crane announced that the first domestic dispersible tablet of Irbesartan passed the consistency evaluation.
    The drug is mainly used for the treatment of essential hypertension and type 2 diabetic nephropathy combined with hypertension.

    As of the date of this announcement, Shuanghe Limin has invested a total of RMB 6,730,500 (unaudited) in the research and development of the drug's consistency evaluation.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.